<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To detect the reattachment rate and visual function outcome of Pars Plana Lensectomy, vitrectomy and scleral encircling (PPL + <z:chebi fb="0" ids="53261">PPV</z:chebi> + SE) to treat <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> (RD) with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A retrospective study of 11 cases of 14 eyes with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> who submitted to PPL + <z:chebi fb="0" ids="53261">PPV</z:chebi> + SE </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> the cases were followed up for four - 46 months (means 31.2 months) </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="46" ids="15035">Retinal</z:chebi> reattachment rate was 85.7%, visual acuity were 0.3 or better in eight cases </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: PPL + <z:chebi fb="0" ids="53261">PPV</z:chebi> + SE is a safe and effective treatment for <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
</text></document>